IMPROVEMENTS IN INSULIN SENSITIVITY SEEN IN PATIENTS WITH TYPE 2 DIABETES AFTER REVITA® DMR IS ASSOCIATED WITH A DECREASE IN GLUCAGON, GLUCOSE, AND GIP AFTER A MIXED MEAL TOLERANCE TEST

Celine Busch: NO financial relationship with a commercial interest | Suzanne Meiring: NO financial relationship with a commercial interest | Annieke Van Baar: NO financial relationship with a commercial interest | Kelly White: YES financial relationship with a commercial interest;Fractyl Health:Employment | Juan Carlos Lopez-Talavera: YES financial relationship with a commercial interest;Fractyl Health:Employment | Moira Hagen: YES financial relationship with a commercial interest;Fractyl Health:Employment;Intercept:Employment | Max Nieuwdorp: YES financial relationship with a commercial interest;Caelus health:Board Membership;Kaleido biosciences:Board Membership | Jacques Bergman: YES financial relationship with a commercial interest;Olympus Tokyo:Grant/Research Support;Olympus Tokyo:Advisory Committees or Review Panels;Medtronic:Advisory Committees or Review Panels;Cdx:Grant/Research Support;Cernostics:Grant/Research Support;Lucid Diagnostics:Grant/Research Support;Fractyl Laboratories:Advisory Committees or Review Panels;Fractyl Laboratories:Grant/Research Support;Digma Medical:Consulting;Digma Medical:Grant/Research Support;Endogenex:Consulting;Endogenex:Grant/Research Support;Aqua Medical:Consulting;Aqua Medical:Grant/Research Support;Falk Medical:Grant/Research Support